Data privacy and users rights

Notice of personal data processing related to safety information

Novo Nordisk A/S is required by law to collect complaints and safety information concerning our products and whilst doing so to also protect your personal data. This Notice explains how we process (e.g. collect, use, store, and share) your personal data. We will process any personal data about you in accordance with this Notice and with applicable law. In Novo Nordisk we collect all safety information on our products into a database. We analyse the data on a regular basis to determine if there is any new information about our products that we need to share with authorities, doctors and patients. This is all done with the purpose of securing the safety of our products and patients.

The company responsible for processing your personal data is:

Novo Nordisk A/S

Novo Alle 1 DK-2880 Bagsvaerd


You can always contact Novo Nordisk or the Novo Nordisk Data Privacy Officer at with questions or concerns about how we process your personal data.

We get your personal data from the following sources:

  • From you directly
  • From Health Care Professionals such as your nurse, a pharmacist or doctor
  • From publicly available publications, websites, or social media

We process personal data about you for the following purposes:

  • To perform a scientific evaluation of any complaint or side effect potentially related to a Novo Nordisk medicinal product
  • To file side effects in our global safety database, which is regularly analysed for overall patterns
  • To assess patterns associated with complaints, including side effects

For the purposes described above in Section 3, we may process the following types of personal data:

  • Contact information (name, address, telephone number, email address)
  • Data revealing racial or ethnic origin
  • Data concerning health and medicinal products you are using

Our processing of your personal data requires a legal basis. By law, we are allowed to process your personal data described above in Section 4 based on the following legal bases:

  • The processing is necessary for our compliance with the legal safety obligation 

We may share your personal data with:

  • Health authorities
  • Other Novo Nordisk entities (e.g., Novo Nordisk affiliates in other countries)
  • Partner companies that assist our company (e.g. licence partners, consultants, IT service providers)
  • Other pharma companies, if a side effect is considered related to their product(s)

For the purposes described above in Section 3, we transfer your personal data to the following countries outside the European Economic Area (EEA):

  • All non-EEA countries in which Novo Nordisk have a physical presence 

We use one of the following safeguards, as required by law, to protect your personal data in case of such transfers:

  • The transfer is to a Novo Nordisk entity covered by Novo Nordisk’s Binding Corporate Rules, available at  

We will keep your personal data for the following period of time:

  • 12 years for data relating to technical complaints
  • Permanently for data relating to side effects
  • Up to 5 years for all other enquiries

In general, you have the following rights:

  • You can get an overview of what personal data we have about you
  • You can get a copy of your personal data in a structured, commonly used and machine-readable format
  • You can get an update or correction to your personal data 
  • You can submit a complaint about how we process your personal data to a Data Protection Authority. 

Under applicable law, there may be limits on these rights depending on the specific circumstances of the processing activity. Contact us as described in Section 1 with questions or requests relating to these rights.